BioCentury
ARTICLE | Strategy

Back to School 1993: The clear route to ROI

Back to School Issue

September 7, 1993 7:00 AM UTC

At least half the industry returns to work today from vacation. We may exaggerate somewhat, but nevertheless we hope the late summer break taken by many biotech investors and executives results in renewed energy for reviving biotech's fortunes. Because it's not overstatement to say that the shape of the industry fundamentally will be determined by management and investor actions during the next year or so.

Simply put, the next 12 to 18 months will provide telling evidence about the sector's ability to meet product milestones, and test whatever novel solutions are crafted against the realities of capital rationing...